UBS

Good Q1 figures, earnings much better than expected

07/05/24 -"• Revenues were up by 17% to $12.8bn for Q1 24 compared to Q4 23 • Total operating expenses declined by 11% to $10.3bn for Q1 24 versus Q4 23 • Net result attributable to shareholders switched from ..."

PDF page sample
Pages
54
Language
English
Published on
07/05/24
Download
You may also be interested by these reports :
17/05/24
As exposed in our previous teaser, DnB’s recipe for success, which allowed the bank to display one of the strongest profitabilities in the sector in ...
17/05/24
Net profit attributable to shares was unchanged at €23m for Q1 24 compared to Q1 23 despite considerably higher loan loss provisions. The net profit ...
17/05/24
We have plugged in the FY 23 and Q1 24 results into our model. Our 2024 and 2025 EPS, respectively a slight upgrade and downgrade, are only the ...
16/05/24
KBC posted a beat in the Q1 driven by higher NII, insurance revenue and a lower cost of risk. The management also seemed confident on its 2024 ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO